BLASI, LORENZO
 Distribuzione geografica
Continente #
EU - Europa 60
NA - Nord America 47
AS - Asia 24
Totale 131
Nazione #
US - Stati Uniti d'America 47
DE - Germania 23
IT - Italia 12
RU - Federazione Russa 11
CN - Cina 9
HK - Hong Kong 7
SG - Singapore 6
GB - Regno Unito 4
SE - Svezia 3
FI - Finlandia 2
UA - Ucraina 2
BG - Bulgaria 1
CZ - Repubblica Ceca 1
IE - Irlanda 1
IN - India 1
TR - Turchia 1
Totale 131
Città #
Chandler 13
Hong Kong 7
Schoenwalde 5
Trieste 5
Beijing 4
Fairfield 4
Santa Clara 4
Boardman 3
Singapore 3
Wilmington 3
Helsinki 2
Jacksonville 2
Moscow 2
Norwalk 2
Pocenia 2
Princeton 2
Rome 2
Ann Arbor 1
Ashburn 1
Brescia 1
Brno 1
Columbus 1
Dallas 1
Dublin 1
Izmir 1
Nanjing 1
Nuremberg 1
Pune 1
Seattle 1
Sofia 1
Venice 1
Wuhan 1
Totale 80
Nome #
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 97
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 40
Totale 137
Categoria #
all - tutte 603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 2 3 2 1 2 0
2020/20215 2 0 0 1 0 0 0 1 0 0 0 1
2021/202212 0 1 0 1 0 0 3 1 2 1 0 3
2022/202321 2 3 3 2 2 3 0 4 2 0 0 0
2023/202440 0 10 2 11 2 2 1 9 0 0 3 0
2024/202523 1 1 6 3 4 4 4 0 0 0 0 0
Totale 137